| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/28/2010 | EP2178375A1 Pyrazoloý1,5-a¨pyrimidine derivatives |
| 04/28/2010 | EP2178373A1 Heterocycles as potassium channel modulators |
| 04/28/2010 | EP2178372A2 Natural bioactive compounds |
| 04/28/2010 | EP2178371A1 Heterocyclic modulators of cannabinoid receptors |
| 04/28/2010 | EP2178370A1 Combinations for the treatment of b-cell proliferative disorders |
| 04/28/2010 | EP2088999B1 Pharmaceutical composition comprising an active ingredient which neutralizes and/or binds gastric acid, such as an alginic acid derivative |
| 04/28/2010 | EP1902047B1 Carboxamide compound and use of the same |
| 04/28/2010 | EP1881967B1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics |
| 04/28/2010 | EP1844776B1 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
| 04/28/2010 | EP1836175B1 Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| 04/28/2010 | EP1805177B1 Pyrrolo[3,2-c]pyridine derivatives and process for the preparation thereof |
| 04/28/2010 | EP1753739B1 Imidazol-2-one compounds useful in the treatment of various disorders |
| 04/28/2010 | EP1729811B1 Cream-gel containing ivermectin |
| 04/28/2010 | EP1720837B1 Derivatives of n-' (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity |
| 04/28/2010 | EP1684750B1 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 04/28/2010 | EP1667694B1 Tlr7 ligands for the treatment of hepatitis c |
| 04/28/2010 | EP1643989B1 Cis-imidazolines as mdm2 inhibitors |
| 04/28/2010 | EP1628980B1 6-arylmethyl-substituted pyrazolopyrimidines |
| 04/28/2010 | EP1596826B1 Use of pvp-iodine liposomes for treatment of atopic dermatitis |
| 04/28/2010 | EP1590321B1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 04/28/2010 | EP1581532B1 Pyrazolo¬3,4-b pyridine compounds, and their use as phosphodiesterase inhibitors |
| 04/28/2010 | EP1572173B1 Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 04/28/2010 | EP1569663B1 Ifosfamide compositions for parenteral administration and a process for their preparation |
| 04/28/2010 | EP1556513B1 Compositions and methods for treating human papillomavirus-mediated disease |
| 04/28/2010 | EP1480650B1 Novel crystalline forms of the anti-cancer compound zd1839 |
| 04/28/2010 | EP1480615B1 Formoterol superfine formulation |
| 04/28/2010 | EP1474142B1 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof |
| 04/28/2010 | EP1472225B1 2-piperazine-pyridines useful for treating pain |
| 04/28/2010 | EP1461339B1 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | EP1356067B1 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs |
| 04/28/2010 | EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 04/28/2010 | EP1295607B1 Antitumor effect potentiators |
| 04/28/2010 | CN1976937B The extract of bulbophgllum radiatum lindl and the preparation and the use |
| 04/28/2010 | CN1961888B Lyophilized powder injection of baikal skullcap root extract and preparation method thereof |
| 04/28/2010 | CN1956732B Antimycobacterial pharmaceutical composition comprising an antitubercular drug |
| 04/28/2010 | CN1954818B Application of phillyrin in preparation for treating endotoxemia |
| 04/28/2010 | CN1943580B New use of fumigacin type steroids in producing medicine for anti-drug fast bacteria |
| 04/28/2010 | CN1923241B Medicine composition containing epimedium extract, uncaria extract, and gastrodine, and its preparation and use |
| 04/28/2010 | CN1903193B Use of Naka-furan-8-lactone |
| 04/28/2010 | CN1901924B Method for inhibiting bacterial colonisation |
| 04/28/2010 | CN1875020B Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same |
| 04/28/2010 | CN1872851B Compound of alpha - methylene - gamma - butyrolactone, preparation method, and method |
| 04/28/2010 | CN1872068B Application of medication composition of containing acetamino phenol in treating insufficiency of blood supply for brain |
| 04/28/2010 | CN1867578B The conjugates of a hydrophilic polymer-buxus's extracts and the pharmaceutical compositions of thereof |
| 04/28/2010 | CN1863526B Collagen productin enhancer and production process and use thereof |
| 04/28/2010 | CN1860228B Staple type oligonucleotide and drug comprising the same |
| 04/28/2010 | CN1857293B Medicine composition containing wild astragaloside and paeoniforin |
| 04/28/2010 | CN1856305B Pyridine derivatives as urotensin II antagonists |
| 04/28/2010 | CN1843368B Breviscapinum long-circulating nanoliposome and its preparation method |
| 04/28/2010 | CN1832939B Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 04/28/2010 | CN1824009B Multipurpose medicinal composition capable of oral administration and external use |
| 04/28/2010 | CN1822843B Process for preparing an antiviral particles |
| 04/28/2010 | CN1816550B Indolyl derivatives substituted with a thiazole ring and their use as PPAR modulators |
| 04/28/2010 | CN1814292B Anti-cancer prodrug, preparing method and use |
| 04/28/2010 | CN1812972B Caspase inhibitors and uses thereof |
| 04/28/2010 | CN1802101B Use of isomalt (mixture of 1,6 GPS and 1,1 GPM) as a prebiotic for the production of a medicament used for the treatment of intestinal diseases, among other things |
| 04/28/2010 | CN1795886B Application of medication composition for preparing medicine for treating cretinism |
| 04/28/2010 | CN1795183B Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 04/28/2010 | CN1785253B Micro-balls of compound red-rooted salvia injection, and its preparation method |
| 04/28/2010 | CN1778322B Chinese medicine for treating cardiovascular disease |
| 04/28/2010 | CN1777419B Pharmaceutical compositions of CETP inhibitors |
| 04/28/2010 | CN1771966B Application of natural beta-carotene oil and beta-carotene crystal |
| 04/28/2010 | CN1767769B Lipid-improving agent and composition containing lipid-improving agent |
| 04/28/2010 | CN1761485B Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 04/28/2010 | CN1758913B Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 04/28/2010 | CN1758906B Compositions for the improvement of obesity |
| 04/28/2010 | CN1747711B Melanogenesis inhibitor and skin preparation containing the same |
| 04/28/2010 | CN1728988B Powdered medicaments containing a tiotropium salt and salmeterol xinafoate |
| 04/28/2010 | CN1717252B Preparation containing basic drug |
| 04/28/2010 | CN1711084B Substituted 4-alkoxyoxazol derivatives as PPAR agonists |
| 04/28/2010 | CN1705479B Use of distrontium 2-(n,n-di(carboxymethyl)amino)-3-cyano-4-carboxymethyl thiophene-5-carboxylate in preparing medicine to reduce gastro-duodenal pain |
| 04/28/2010 | CN1703199B Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially throug |
| 04/28/2010 | CN1700917B Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 04/28/2010 | CN1691965B Pharmaceutical composition for controlled release and manufacturing method thereof |
| 04/28/2010 | CN1690066B Antiviral agent cidofovir derivatives |
| 04/28/2010 | CN1686112B Use of cnidicin and preparation used for treating fatty liver |
| 04/28/2010 | CN1682719B Enteric soluble coating slow releasing tablet containing huperzine A and preparing method |
| 04/28/2010 | CN1679403B Fat or oil processing food |
| 04/28/2010 | CN1676521B Kuh-seng ketone and its derivative and the like and use in preparing anti-tumor medicine |
| 04/28/2010 | CN1674853B Drug eluting coatings for medical implants |
| 04/28/2010 | CN1668290B Modified amino acid for the inhibition of platelet aggregation |
| 04/28/2010 | CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/28/2010 | CN1658855B O-substituted hydroxyaryl derivatives |
| 04/28/2010 | CN1654041B Application of eagle-tea extract total flavone in preparation of medicine for regulating blood fat |
| 04/28/2010 | CN1652698B Method and dietary composition for improving lipid digestibility |
| 04/28/2010 | CN1652697B Method and dietary composition for improving fat digestibility |
| 04/28/2010 | CN1652696B Method of improving absorption of vitamin E by a pet animal |
| 04/28/2010 | CN1620284B Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tool for producing it |
| 04/28/2010 | CN1620257B Matrix-forming composition containing pectin |
| 04/28/2010 | CN1615971B Injection emulsion for refreshment and its preparing method |
| 04/28/2010 | CN1611509B Nucleic acid adaptor for specific identifying human cerebral acetylcholinesterase and its use |
| 04/28/2010 | CN1596266B Specific binding agents of human angiopoietin-2 |
| 04/28/2010 | CN1593473B Application of a pharmaceutical composition in the preparing process of medicine for treating chronic alcohol intake caused injury |
| 04/28/2010 | CN1593461B Manufacture method of nutrient oral liquor of ass hide glue flavone |
| 04/28/2010 | CN1582946B Use of centellosic acid derivative in preparation of medicines for diseases of cardio-cerebral blood vessels |
| 04/28/2010 | CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine, |
| 04/28/2010 | CN1556705B 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives |
| 04/28/2010 | CN1553906B VARIOLIN derivatives and their use as antitumor agents |